 |
| Todd Eury |
Finn Partners Acquires Pharmacy Podcast Network
Finn Partners is acquiring Pharmacy Podcast Network, which reaches more than 120K monthly listeners in the pharmacy sector, on Dec. 1.
PPN and its digital magazine, Rx Influencer, will operate as a division of Finn Partners led by executive producer & VP Todd Eury.
Pittsburgh-based Eury will report to Gil Bashe, Finn Partners’ global health chair.
“Pharmacy is the cornerstone for consumer care and public health action,” Bashe told O’Dwyer’s. “Pharmacy Podcast Network has risen to the top of the ranks as one of the most respected sources for health leaders – payer, product innovation and policymakers – to share breaking news and address pressing issues with the nation’s most trusted health professionals.”
Calling pharmacists central in every health setting, Eury said, “PPN has evolved into the go-to content and digital platform for connection to this influential audience.”
Eury will maintain control over PPN content decisions, while Finn Partners will have a direct connection to breaking trends, policies and needs of the front-line health professional community.
Bashe noted that pharmacists “demonstrated their life-saving importance once again in responding to the COVID-19 vaccination urgencies.”
They also are leaders in consumer personal care, over-the-counter products and behind-the-counter devices to monitor healthcare concerns.
Finn Partners ranked No. 4 in O’Dwyer’s healthcare rankings with $34.1M in fee income for 2020.
To negotiate the demands of media, investors, regulators and the market, communicators to make sure that their narrative they construct is defensible every stop of the way.
In a health landscape crowded with claims, brands earn trust by pairing credible proof with human stories, cultural relevance, and empowerment.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
